← All organizations

The Pacific Pediatric Neuro-Oncology Consortium

Academic/HospitalWebsite ↗

Also known as: Pacific Pediatric Neuro-Oncology Consortium | Pediatric Neuro-Oncology Consortium

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 28, 2026

Timeline

2010s

Jan 1, 2012
The Pacific Pediatric Neuro-Oncology Consortium— Founded

Drugs by trial phase (13 distinct, 12 trials)

Phase 3 (1 own, 0 via acquisition)

tozuleristide

Phase 2 (7 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT07226453CollaboratorPhase 2Feb 28, 2026
NCT06861244CollaboratorPhase 2Mar 6, 2025
NCT04573140CollaboratorPhase 1Oct 26, 2021
NCT04775485CollaboratorPhase 2Mar 17, 2021
NCT04323046CollaboratorPhase 1Jun 1, 2020
NCT03893487CollaboratorEarly Phase 1Jul 31, 2019
NCT03749187CollaboratorPhase 1Apr 3, 2019
NCT03690869CollaboratorPhase 1/Phase 2Sep 28, 2018
NCT03579602CollaboratorPhase 2/Phase 3Aug 31, 2018
NCT03566199CollaboratorPhase 1/Phase 2May 22, 2018
NCT03429803CollaboratorPhase 1/Phase 2Feb 27, 2018
NCT03231306CollaboratorPhase 2Nov 28, 2017

Details

Founded: San Francisco, CA, US Jan 1, 2012
Last known activity: Feb 28, 2026